Immunology
News
Many physicians don’t teach epinephrine use for food allergies
Many pediatricians and allergists failed to provide instructions for when and how to use epinephrine and a written emergency action plan to the...
News
PPIs caused remission in about half of esophageal eosinophilia cases
About half of patients with symptomatic esophageal eosinophilia achieved complete clinical and histologic remission on proton pump inhibitors,...
News
Reslizumab: FDA panel recommends approval for adults, but not children
An FDA advisory committee voted to approve reslizumab, a Teva-sponsored drug treating severe asthma, for use in patients aged 18 years and older,...
Conference Coverage
Busting eczema treatment myths: applying the evidence
News
FDA approves mepolizumab for use in combination with other asthma drugs
Nucala (mepolizumab) has been approved for use with other asthma medicines as maintenance therapy for patients aged 12 years and older with a...
Conference Coverage
EADV: Another promising topical for atopic dermatitis
Key clinical point: The pipeline for nonsteroidal topical therapies for pediatric and adult atopic dermatitis shows great promise. Major finding:...
Commentary
No flu vaccine for patients with egg allergy?
Conference Coverage
EADV: Novel topical crisaborole shines in atopic dermatitis
Crisaborole topical ointment 2% b.i.d. appeared to be a safe and effective treatment for mild to moderate atopic dermatitis in children and adults...
News
Peripartum probiotics linked to lower atopic dermatitis risk in offspring
Peripartum consumption of probiotic milk was associated with a decline in the incidence of atopic dermatitis in offspring.
News
AAP: Give peanut products to high-risk infants to cut allergy risk
Medical groups advise early peanut introduction in those with eczema with or without egg allergy.
News
New HPV vaccine safe with meningitis, Tdap vaccines
Key clinical point: The new 9-valent HPV vaccine can be given with other standard vaccines in one visit. Major finding: No difference in safety or...